Il Nostro Team
Comunicazioni tecniche
Eventi
Fare News
Imprese Associate
{{ fifthTitle }}

FARE INSIEME - Ep. 82 - Biolchim, people in the middle and research in the plural

«We have had strong relationships with customers and suppliers for over 30 years»

10/10/2022

Go to the podcast.
 

It is one of the most dynamic companies in the international biostimulants landscape. Its business model, which is also the basis of the organizational sphere, is focused on continuous innovation and cross-cutting alliances. Roots anchored in the community, but capable of spreading everywhere across the world. The company is present in more than 80 countries in Europe, Africa, Asia and South America. Giampaolo Colletti interviews Leonardo Valenti, CEO of Biolchim for FARE INSIEME

of Giampaolo Colletti
@gpcolletti

“Where you tend a rose, a thistle cannot grow. Forgetting how to hoe the ground and take care of the soil means forgetting yourself”. So tells an old adage, which inevitably recalls the strength of the earth, its preservation, its well-being and ultimately our own. Well, there is an Emilia-based company that has been on the scene for 50 years—literally! – to take care of the land. This is Biolchim, a jewel of Bologna that is engaged in the production and marketing of specific fertilizers with special biostimulants. They are high-added-value products that combine agronomic efficiency and environmental sustainability. It all began in 1972. We are in Medicina, a town with less than twenty thousand inhabitants in the metropolitan area of ​​Bologna. A small piece of land that stretches for almost 160 square kilometers across the Emilian plain, irrigated by the canal that also gives its name to the historic San Vitale Road. Here we find the plant where the entire production cycle is carried out, including the final packaging of the products, which are then shipped around the world. Roots anchored in the community, but capable of spreading everywhere in the world. The company is present in more than 80 countries in Europe, Africa, Asia, and South America. Biolchim operates with its own subsidiaries in Brazil, Germany, Poland, Hungary, China, New Zealand and Australia, while in Turkey, Lebanon, India and Russia, local distributors are supported by a network of local technicians. The rest of the countries rely on established business partnerships and a broad network of distributors and importers. There has been a focus on proprietary technologies for producing strategic raw materials and a solid platform of knowledge and innovation.

In the direction of continuous innovation.
Even today, Biolchim offers its customers a comprehensive portfolio of safe and effective products that help maximize the yield of every crop, anywhere in the world. Since 2014, it has led a group of five companies that rank among the top players in the industry. “We are celebrating our fiftieth birthday this year. The companies we have bought are even more historic than we are and pioneers in their respective industries, but ultimately, like us, they have a strong drive for innovation. Thus, innovation is strengthened, reinforced and supported by experience and solid pragmatism. We want to consolidate the sector by buying suppliers and competitors who then integrate well", said Leonardo Valenti, CEO at Biolchim. Top-breaking figures for a specialized and fragmented niche sector: 2021 was closed at €142 million with a team of 420 people, while the forecast for 2022 was €155 million. The group is active in plant nutrition and care and 90% of its activity is in professional agriculture. The supply is based on innovative fertilizers, bio-stimulants, biocontrol solutions and generally on products aimed at sustainable organic or conventional farming. This requires continued attention to the product, process and technical service innovation, as well as organizational arrangements that are best suited to the demand for effective, but also environmentally friendly solutions.

People first.
Of course, we are talking about hi-tech solutions, but what makes the difference is people, inside and outside the company. Valenti is convinced of that. “We have had strong relationships with customers and suppliers for up to thirty years. Our employee turnover is very low, and we pay close attention to the issues of inclusion and diversity. After all, the international nature of our activity makes us a melting pot of cultures. And we also have a lot of women in top positions. Ours is a niche industry and the quality of people makes the difference. That is why we tend to hire our employees directly from universities and then train them internally". Research in the plural. Biolchim has partnered with dozens of companies and is now involved in more than one hundred open collaborations with research centers, labs, universities and industrial partners such as customers and suppliers or spinoffs. In 2012, the WIN project—an acronym for Worldwide Innovation Network—was launched: It consists of a platform for scientific and technical cooperation, aimed at innovation in five areas: product innovation, process innovation, packaging innovation, technical support for farmers and organizational models. "It's a new global, reticular and successful research model. Developing the network means looking for quality, mutually beneficial partnerships and specializations, even outside our industry. We have worked very hard, for example, with pharmaceutical botany and we depend on continuous improvement. At the heart of our corporate mission is the desire to provide farmers with effective and efficient solutions for their day-to-day work in the fields. Long years of experience, concreteness and attention to the needs of the end user are the tools through which we shape our commercial offer, which is strongly focused on the core themes of product and service. Our main goal is to ensure that farmers always perceive our company as a reliable partner that can provide them with winning technical solutions”, explains Valenti. For him and his team, farming is now unthinkable without objective diagnostic tools, because these are also going through a phase of profound technological transformation identical to the one that has already occurred in medicine. The study of symptoms has given way to objective evidence through analysis. The digital sphere is essential, and the process is irreversible. But at the heart are and always will be human beings.

https://podcast.confindustriaemilia.it/

Read the other interviews

 

Altri Articoli di Fare news